Find out if you are eligible for this trial
This study involves receiving 3 doses of a novel malaria vaccine candidate, each administered one month apart. One month following the final vaccine dose, participants will receive an injection with infectious malaria parasites to examine the effectiveness of the vaccine. If there is evidence of a developing malaria infection/at the completion of the study, anti-malarial drugs will be administered. Reasonable travel and parking costs will be reimbursed as well as a nominal fee for reimbursement of time ($50/visit).
- Healthy males aged 18-50 years of age who are non-smokers/smoke ≤ 5 cigarettes/day.
- Further eligibility criteria will be assessed in screening visits and involve assessment of medical history and blood test results.